{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:59:59Z","timestamp":1718128799225},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T00:00:00Z","timestamp":1259107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10238-009-0080-y","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T14:16:22Z","timestamp":1259072182000},"page":"179-184","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women"],"prefix":"10.1007","volume":"10","author":[{"given":"Ramazan","family":"Sari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esin","family":"Eray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahat","family":"Ozdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halide","family":"Akbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkan","family":"Coban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,25]]},"reference":[{"key":"80_CR1","first-page":"97","volume":"5","author":"B Larsson","year":"1981","unstructured":"Larsson B, Bj\u00f6rntorp P, Tibblin G (1981) The health consequences of moderate obesity. Int J Obes Relat Metab Disord 5:97\u2013106","journal-title":"Int J Obes Relat Metab Disord"},{"key":"80_CR2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199509143331101","volume":"333","author":"JE Manson","year":"1995","unstructured":"Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE (1995) Body weight and mortality among women. N Engl J Med 333:677\u2013685","journal-title":"N Engl J Med"},{"issue":"6","key":"80_CR3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0955-2863(02)00187-0","volume":"13","author":"LK Heilbronn","year":"2002","unstructured":"Heilbronn LK, Clifton PM (2002) C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss. J Nutr Biochem 13(6):316\u2013321","journal-title":"J Nutr Biochem"},{"issue":"3","key":"80_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.metabol.2005.09.010","volume":"55","author":"A Dvorakova-Lorenzova","year":"2006","unstructured":"Dvorakova-Lorenzova A, Suchanek P, Havel PJ, Stavek P, Karasova L, Valenta Z, Tintera J, Poledne R (2006) The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55(3):359\u2013365","journal-title":"Metabolism"},{"issue":"4","key":"80_CR5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/CS20040111","volume":"107","author":"MJ Sharman","year":"2004","unstructured":"Sharman MJ, Volek JS (2004) Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond) 107(4):365\u2013369","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"80_CR6","first-page":"4","volume":"17","author":"JP Bastard","year":"2006","unstructured":"Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17(1):4\u201312","journal-title":"Eur Cytokine Netw"},{"issue":"3","key":"80_CR7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1081\/ERC-200033541","volume":"30","author":"E Coban","year":"2004","unstructured":"Coban E, Sari R (2004) The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidemic obese patients. Endocr Res 30(3):343\u2013349","journal-title":"Endocr Res"},{"key":"80_CR8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0149-2918(96)80057-9","volume":"18","author":"FX Pi-Sunyer","year":"1996","unstructured":"Pi-Sunyer FX (1996) A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther 18:1006\u20131036","journal-title":"Clin Ther"},{"key":"80_CR9","first-page":"397","volume":"16","author":"DJ Goldstein","year":"1992","unstructured":"Goldstein DJ (1992) Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 16:397\u2013415","journal-title":"Int J Obes Relat Metab Disord"},{"key":"80_CR10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/oxfordjournals.aje.a117386","volume":"141","author":"DF Williamson","year":"1995","unstructured":"Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C (1995) Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40\u201364\u00a0years. Am J Epidemiol 141:1128\u20131141","journal-title":"Am J Epidemiol"},{"key":"80_CR11","first-page":"30S","volume":"21","author":"MEJ Lean","year":"1997","unstructured":"Lean MEJ (1997) Sibutramine: a review of clinical efficacy. Int J Obes Relat Metab Disord 21:30S\u201336S","journal-title":"Int J Obes Relat Metab Disord"},{"key":"80_CR12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1345\/aph.18319","volume":"33","author":"CA Luque","year":"1999","unstructured":"Luque CA, Rey JA (1999) Sibutramine: a serotonin re-uptake inhibitor for the treatment of obesity. Ann Pharmacother 33:968\u2013978","journal-title":"Ann Pharmacother"},{"issue":"9","key":"80_CR13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archinte.164.9.994","volume":"164","author":"DE Arterburn","year":"2004","unstructured":"Arterburn DE, Crane PK, Veenstra DL (2004) The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med 164(9):994\u20131003","journal-title":"Arch Intern Med"},{"key":"80_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1463-1326.2002.00181.x","volume":"4","author":"A Gokcel","year":"2002","unstructured":"Gokcel A, Gumurdulu Y, Karakose H, Ertorer EM, Tanaci N, Tutuncu NB, Guvener N (2002) Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. Diabetes Obes Metab 4:49\u201355","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"80_CR15","first-page":"675","volume":"26","author":"B Baranowska","year":"2005","unstructured":"Baranowska B, Wolinska-Witort E, Martynska L, Chmielowska M, Mazurczak-Pluta T, Boguradzka A, Baranowska-Bik A (2005) Sibutramine therapy in obese women\u2014effects on plasma neuropeptide Y (NPY), insulin, leptin and beta-endorphin concentrations. Neuro Endocrinol Lett 26(6):675\u2013679","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"80_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1185\/030079905X38132","volume":"21","author":"TD Filippatos","year":"2005","unstructured":"Filippatos TD, Kiortsis DN, Liberopoulos EN, Mikhailidis DP, Elisaf MS (2005) A review of the metabolic effects of sibutramine. Curr Med Res Opin 21(3):457\u2013468","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"80_CR17","first-page":"605","volume":"28","author":"J Wu","year":"2003","unstructured":"Wu J, Lei MX, Chen HL (2003) Serum leptin and insulin resistance in obesity and effects of sibutramine on them. Hunan Yi Ke Da Xue Xue Bao 28(6):605\u2013607","journal-title":"Hunan Yi Ke Da Xue Xue Bao"},{"issue":"4","key":"80_CR18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.metabol.2003.11.022","volume":"53","author":"G Valsamakis","year":"2004","unstructured":"Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett AH, Kumar S (2004) Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 53(4):430\u2013434","journal-title":"Metabolism"},{"issue":"2","key":"80_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006676-200108000-00010","volume":"23","author":"I Yip","year":"2001","unstructured":"Yip I, Go VL, Hershman JM, Wang HJ, Elashoff R, DeShields S, Liu Y, Heber D (2001) Insulin-leptin-visceral fat relation during weight loss. Pancreas 23(2):197\u2013203","journal-title":"Pancreas"},{"key":"80_CR20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1380269","volume":"138","author":"E Diamanti-Kandarakis","year":"1998","unstructured":"Diamanti-Kandarakis E, Kouli C, Tsianeteli T, Bergiele A (1998) Therpeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 138:269\u2013274","journal-title":"Eur J Endocrinol"},{"key":"80_CR21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","volume":"43","author":"EM Velazquez","year":"1994","unstructured":"Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure while facilitating normal menses and pregnancy. Metabolism 43:647\u2013654","journal-title":"Metabolism"},{"issue":"3","key":"80_CR22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2337\/diabetes.55.03.06.db05-0917","volume":"55","author":"YW Kim","year":"2006","unstructured":"Kim YW, Kim JY, Park YH, Park SY, Won KC, Choi KH, Huh JY, Moon KH (2006) Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance. Diabetes 55(3):716\u2013724","journal-title":"Diabetes"},{"issue":"9","key":"80_CR23","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1464-5491.2005.01632.x","volume":"22","author":"AM Carter","year":"2005","unstructured":"Carter AM, Bennett CE, Bostock JA, Grant PJ (2005) Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus. Diabet Med 22(9):1282\u20131284","journal-title":"Diabet Med"},{"issue":"5","key":"80_CR24","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2337\/diabetes.54.5.1566","volume":"54","author":"S Haffner","year":"2005","unstructured":"Haffner S, Temprosa M, Crandall J, Fowler S, Goldberg R, Horton E, Marcovina S, Mather K, Orchard T, Ratner R, Barrett-Connor E (2005) Diabetes Prevention Program Research Group. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 54(5):1566\u20131572","journal-title":"Diabetes"},{"key":"80_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1037\/0022-006X.65.1.79","volume":"65","author":"GD Foster","year":"1997","unstructured":"Foster GD, Wadden TA, Vogt RA (1997) What is reasonable weight loss?: patients\u2019 expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol 65:79\u201385","journal-title":"J Consult Clin Psychol"},{"key":"80_CR26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1992.69","volume":"51","author":"M Weintraub","year":"1992","unstructured":"Weintraub M, Sundaresan PR, Madan M, Schuster B, Balder A, Lasagna L, Cox C (1992) Long-term weight control study I (weeks 0 to 34): the enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Clin Pharmacol Ther 51:586\u2013594","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl 2","key":"80_CR27","first-page":"51S","volume":"6","author":"National Heart, Lung, and Blood Institute","year":"1998","unstructured":"National Heart, Lung, and Blood Institute (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report (review). Obes Res 6(suppl 2):51S\u2013209S","journal-title":"Obes Res"},{"key":"80_CR28","volume-title":"Prevention and management of the global epidemic of obesity: report of the WHO consultation on obesity","author":"World Health Organization","year":"1998","unstructured":"World Health Organization (1998) Prevention and management of the global epidemic of obesity: report of the WHO consultation on obesity. World Health Organization, Geneva Report WHO\/NUT\/NCD\/98.1."},{"issue":"4","key":"80_CR29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","volume":"87","author":"SA Arslanian","year":"2002","unstructured":"Arslanian SA, Lewy V, Danadian K, Saad R (2002) Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: Amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance. J Clin Endocrinol Metab 87(4):1555\u20131559","journal-title":"J Clin Endocrinol Metab"},{"key":"80_CR30","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","volume":"85","author":"R Pasquali","year":"2000","unstructured":"Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM (2000) Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels, in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85:2767\u20132774","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"80_CR31","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1053\/meta.2001.28078","volume":"50","author":"JP Kay","year":"2001","unstructured":"Kay JP, Alemzadeh R, Langley G, D\u2019Angelo L, Smith P, Holshouser S (2001) Benefical effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 50(12):1457\u20131461","journal-title":"Metabolism"},{"issue":"4","key":"80_CR32","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1542\/peds.107.4.e55","volume":"107","author":"M Freemark","year":"2001","unstructured":"Freemark M, Bursey D (2001) The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 107(4):E55","journal-title":"Pediatrics"},{"key":"80_CR33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM198811033191801","volume":"319","author":"PD Wood","year":"1988","unstructured":"Wood PD, Stefanick M, Dreon DM, Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT, Superko HR, Fortmann SP, Albers JJ, Vranizan KM (1988) Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 319:1173\u20131179","journal-title":"N Engl J Med"},{"issue":"Supplement 3","key":"80_CR34","first-page":"41","volume":"22","author":"FJ Smith","year":"1998","unstructured":"Smith FJ, Rivera I, Tanenbaum R, Smith W, Campfield LA (1998) Weight loss reverses decreased sensitivity to exogenous ob protein (leptin) in diet-induced obese mice. Int J Obes 22(Supplement 3):41\u201346","journal-title":"Int J Obes"},{"key":"80_CR35","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/j.1550-8528.1997.tb00579.x","volume":"5","author":"RL Atkinson","year":"1997","unstructured":"Atkinson RL, Blank RC, Schumacher D, Dhurandhar NV, Ritch DL (1997) Long-term drug treatment of obesity in a private practice setting. Obes Res 5:578\u2013586","journal-title":"Obes Res"},{"issue":"6","key":"80_CR36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/oby.2000.53","volume":"8","author":"TA Wadden","year":"2000","unstructured":"Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Arnold ME, Steinberg CM (2000) Effects of sibutramine plus orlistat in obese women following 1\u00a0year of treatment by sibutramine alone: a placebo-controlled trial. Obes Res 8(6):431\u2013437","journal-title":"Obes Res"},{"issue":"2","key":"80_CR37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1081\/ERC-200027356","volume":"30","author":"R Sari","year":"2004","unstructured":"Sari R, Balci MK, Cakir M, Altunbas H, Karayalcin U (2004) Comparison of efficacy of sibutramine or orlistat versus their combination in obese women. Endocr Res 30(2):159\u2013167","journal-title":"Endocr Res"},{"issue":"8","key":"80_CR38","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.ijo.0802707","volume":"28","author":"R Sari","year":"2004","unstructured":"Sari R, Balci MK, Coban E, Yazicioglu G (2004) Comparison of the effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women. Int J Obes Relat Metab Disord 28(8):1059\u20131063","journal-title":"Int J Obes Relat Metab Disord"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-009-0080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-009-0080-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-009-0080-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T11:37:34Z","timestamp":1559129854000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-009-0080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,25]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1007\/s10238-009-0080-y","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,25]]}}}